Eli Health Expands Hormometer to Testosterone

Eli Health has announced an expansion of its Hormometer platform to include testing for testosterone and progesterone. Previously focused on cortisol, the at-home device utilizes a saliva sample collected via a wand and cartridge. Users place the device in their mouth for approximately 60 seconds. The accompanying smartphone app then uses the phone's camera to analyze the sample. The entire testing process takes about 20 minutes.

While the testing mechanism remains unchanged from the previous year, the company is now offering tracking for three distinct hormones on a single platform. Eli Health projects that individual tests will be available starting at $8.25. The announcement was made at the Consumer Electronics Show (CES), marking the company's return to the event to showcase its updated health technology offerings.

The Hormometer operates using a simple, non-invasive procedure that relies on saliva collection. Users are instructed to insert a thin cartridge attached to a wand into their mouth. This process must be maintained for approximately 60 seconds to ensure adequate sample collection. The design prioritizes user convenience by eliminating the need for blood draws or complex laboratory equipment.

Once the sample is collected, the analysis is handled entirely by a smartphone application. The Eli app utilizes the phone's built-in camera to scan and analyze the saliva sample. This technological integration allows for rapid processing without external hardware. The company states that the complete testing cycle, from collection to result, takes approximately 20 minutes. This workflow remains consistent with the cortisol testing model introduced by the company previously.

At the Consumer Electronics Show (CES), Eli Health revealed that the platform is no longer limited to cortisol analysis. The system now supports tracking for testosterone and progesterone. This expansion transforms the device into a multi-hormone monitoring tool accessible from home. Users can now track three different biomarkers using the same hardware and application interface.

The core difference in the latest iteration is the software update allowing for this broader scope of monitoring. The physical hardware and the method of interaction remain the same as the previous version. By keeping the hardware consistent, the company ensures that existing users can access the new testing capabilities easily. The focus is on providing a low price point for these expanded capabilities.

Eli Health has set a target price point to make hormone testing more accessible to the general public. The company anticipates that individual tests will start at $8.25. This pricing strategy aims to undercut traditional laboratory testing costs significantly. It positions the Hormometer as a cost-effective solution for regular hormone monitoring.

The announcement at CES highlights the company's commitment to bringing consumer electronics and healthcare together. By leveraging the ubiquity of smartphones, Eli Health reduces the barrier to entry for personal health diagnostics. The availability of testosterone and progesterone testing alongside cortisol offers a comprehensive view of hormonal health.

The Hormometer represents a significant step forward in at-home health diagnostics. By expanding its capabilities to include testosterone and progesterone, Eli Health provides a versatile tool for individuals monitoring their hormonal health. The combination of saliva-based sampling and smartphone analysis offers a user-friendly experience. With a projected starting price of $8.25 per test, the platform is poised to make regular hormone tracking more accessible than ever before.